Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Insite, MyCare Psychiatry, PERSERIS, Trinomia and Vascepa. Its lead product is Clozaril, which is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Trinomia product related to the treatment of cardiovascular disease.


TSX:HLS - Post by User

Bullboard Posts
Comment by Bobwinson Aug 09, 2012 5:32pm
199 Views
Post# 20200638

RE: RE: Interesting, but still cautious

RE: RE: Interesting, but still cautious

 

how often do you want the contract renewed?

 

Automodular Announces Oakville Contract Extension

Ajax - June 27, 2011

Automodular Corporation ("Automodular") announces that it has signed a multi-year agreement ("MYA") with Ford Motor Company ("Ford") for an extension of services at its Oakville operations. Automodular sub-assembles, sequences and delivers engines, suspension and instrument panel modules for the Ford Edge, Ford Flex, Lincoln MKX and Lincoln MKT being produced in Ford's flexible assembly complex in Oakville, Ontario. This MYA will end in June, 2014.

The MYA provides for certain price reductions over the course of the agreement some of which are retroactive to January 1, 2011. The impact on previously reported first quarter 2011 financial results is a reduction in revenues and pre-tax earnings of
.6 million and a reduction in net earnings of
.4 million.

Automodular is a supplier of sub-assembly, sequencing and transportation services to Ford's Oakville Assembly Plant. The Company has two operating facilities and employs approximately 500 people.


For further information, contact:

Christopher Nutt 
Vice President, Finance 
Automodular Corporation 
(905) 619 4202 

Bullboard Posts